Health Technology

View AMCP comments in response to the 21st Century Cures 2.0 Request for Information.

Discover how health technology assessment (HTA) and value assessment frameworks play a crucial role in evaluating pharmaceuticals and health interventions. The recent multistakeholder Partnership Forum, hosted by AMCP, delved into recognizing value within resource constraints. Key takeaways include emphasizing innovative pharmaceutical products, comprehensive data, and the need for trusted value assessments in healthcare decision-making. Explore best practices for enhancing value assessment tools and processes across the industry.

Partnership Forum: Participants discussed how digital therapeutics with web and designed based applications are emerging as a means to treat conditions by engaging people to improve health and wellness.

Managed care pharmacy and prescription drug coverage is a growing part of the American health care sector. AMCP launched the annual Access, Affordability, and Outcomes report to raise awareness of the existence, prevalence, and importance of managed care pharmacy.

Last week, nearly 50 experts in managed care convened for AMCP’s Partnership Forum: Health Technology Assessment and Value Frameworks to Inform Coverage Reimbursement.

Partnership Forum: This Partnership Forum identified opportunities to improve how value assessments are developed and applied to formulary decision-making and provide strategies and guidance on best practices to equip managed care pharmacists and other professionals when applying these tools to assess value and optimize patient care.

Health care expert Fred Goldstein of AMCP Podcast Powered by PopHealth Week sits down with Patrick Gleason, PharmD, assistant vice president for health outcomes at Prime Therapeutics, and Nick Friedlander, PharmD, clinical programs pharmacist also in the health outcomes division at Prime Therapeutics, to discuss the digital therapeutics landscape.